Table 2.

The susceptibility of the clinical isolates to antibiotics and haloamines

Bacterium	Resistant against*	Time for ≥3log10 reduction of c.f.u. ml−1 (min)†
		1 % NCT (55 mM)	0.001 % BAT (32 µM) 0.02 % NBrT (1 mM)
P. fluorescens	Imipenem, meropenem	15	1
S. lugdunensis	None	15	1
A. viridans	None	>30‡	1
B. pumilus	Cefuroxime, fosfomycin, cefotaxime, cefepime	15	1
K. marina	None	30	1
S. epidermidis	Erythromycin	30	1
S. capitis	Penicillin, ampicillin	30	1

*Determined by agar diffusion tests according to European Committee on Antimicrobial Susceptibility Testing standards [24].

†Tests were done in 0.1M phosphate buffer at pH 7.1 and 37 °C; 1×10⁶ c.f.u. ml⁻¹ were incubated in test solutions and quantitative cultures were assessed after inactivation of the antiseptics with 1 % methionine/1 % histidine.

‡2 log₁₀ reduction after 30 min.